A randomized clinical pharmacokinetic trial of Tenofovir in blood, plasma and urine in adults with perfect, moderate and low PrEP adherence: the TARGET study

BACKGROUND: Tenofovir disoproxil fumarate (TDF) is key component of pre-exposure prophylaxis (PrEP) and antiretroviral therapy (ART) for HIV, but existing tools to monitor drug adherence are often inaccurate. Detection of tenofovir (TFV) in accessible biological samples, such as fingerprick blood, u...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:BMC Infect Dis
Κύριοι συγγραφείς: Cressey, Tim R., Siriprakaisil, Oraphan, Klinbuayaem, Virat, Quame-Amaglo, Justice, Kubiak, Rachel W., Sukrakanchana, Pra-ornsuda, Than-in-at, Kanchana, Baeten, Jared, Sirirungsi, Wasna, Cressey, Ratchada, Drain, Paul K.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: BioMed Central 2017
Θέματα:
Study Protocol
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5513124/
https://ncbi.nlm.nih.gov/pubmed/28705153
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-017-2593-4
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια